Abstract: Disclosed are compounds according to Formula (I) or (II), and pharmaceutical compositions comprising them. Also disclosed are therapeutic methods, e.g., of treating kidney diseases, using the compounds of Formula (I) or (II).
Type:
Grant
Filed:
March 5, 2019
Date of Patent:
April 11, 2023
Assignee:
Goldfinch Bio, Inc.
Inventors:
Matthew H. Daniels, Maolin Yu, Jean-Christophe P. Harmange, Thomas T. Tibbitts, Mark W. Ledeboer, Neil A. Castle, Goran Malojcic
Abstract: Disclosed are compounds according to Formula (I), and related pharmaceutical compositions. Also disclosed are therapeutic methods, e.g., of treating kidney diseases, using the compounds of Formula (I).
Type:
Grant
Filed:
May 18, 2020
Date of Patent:
June 29, 2021
Assignee:
Goldfinch Bio, Inc.
Inventors:
Mark W. Ledeboer, Matthew H. Daniels, Maolin Yu, Jean-Christophe P. Harmange
Abstract: Disclosed are compounds according to Formula (I) or (II), and pharmaceutical compositions comprising them. Also disclosed are therapeutic methods, e.g., of treating kidney diseases, using the compounds of Formula (I) or (II).
Type:
Application
Filed:
August 3, 2018
Publication date:
April 22, 2021
Applicant:
Goldfinch Bio, Inc.
Inventors:
Mark W. Ledeboer, Jean-Christophe P. Harmange, Thomas T. Tibbitts
Abstract: Disclosed are compounds according to Formula (I), and related pharmaceutical compositions. Also disclosed are therapeutic methods, e.g., of treating kidney diseases, using the compounds of Formula (I).
Type:
Grant
Filed:
September 18, 2019
Date of Patent:
May 19, 2020
Assignee:
Goldfinch Bio, Inc.
Inventors:
Mark W. Ledeboer, Matthew H. Daniels, Maolin Yu, Jean-Christophe P. Harmange